Publication Name	World Journal of Clinical Cases
Manuscript ID	78473
Country	China

Received	2022-07-07 04:34
Peer-Review Started	2022-07-07 04:35
To Make the First Decision
Return for Revision	2022-08-01 08:30
Revised	2022-08-10 16:37
Second Decision	2022-09-05 03:24
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-09-05 20:24
Articles in Press	2022-09-05 20:24
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-09-01 04:06
Typeset the Manuscript	2022-09-20 02:37
Publish the Manuscript Online	2022-09-29 09:17

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Case Report
Article Title	Glucocorticoids combined with tofacitinib in the treatment of Castleman's disease: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Xiao-Rui Liu and Mei Tian
ORCID	Author(s) ORCID Number Xiao-Rui Liu http://orcid.org/0000-0003-1518-8811 Mei Tian http://orcid.org/0000-0002-1633-2988
Funding Agency and Grant Number
Corresponding Author	Mei Tian, MD, PhD, Chief Doctor, Doctor, 内科, 遵义医科大学附属医院, 遵义市汇川区大连路149号, 遵义市 563000, 贵州省, China. 348820517@qq.com
Key Words	Castleman's disease; Multicentric Castleman's disease; Idiopathic multicentric Castleman's disease; Abdominal dropsy; Tofacitinib; Glucocorticoids; Case report
Core Tip	Castleman's disease (CD) is a rare proliferative disease of lymphoid tissue. The exact pathogenesis of CD remains unclear and is thought to be related to autoimmune diseases, viral infections and malignancies. The current preferred treatment for idiopathic multicentric CD (iMCD) is interleukin-6 inhibitors but there are still some patients who do not respond well to IL-6 inhibitors. In this paper, we report on a patient with iMCD having multiregional lymph node enlargement combined with malignant ascites who improved after treatment with janus kinase inhibitors.
Publish Date	2022-09-29 09:17
Citation	Liu XR, Tian M. Glucocorticoids combined with tofacitinib in the treatment of Castleman's disease: A case report. World J Clin Cases 2022; 10(29): 10794-10802
URL	https://www.wjgnet.com/2307-8960/full/v10/i29/10794.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i29.10794

Full Article (PDF)	WJCC-10-10794.pdf
Full Article (Word)	WJCC-10-10794.docx
CARE Checklist–2016	78473-CARE-Checklist–2016-revision.pdf
Manuscript File	78473_Auto_Edited-LM.docx
Answering Reviewers	78473-Answering reviewers.pdf
Audio Core Tip	78473-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	78473-Conflict-of-interest statemen.pdf
Copyright License Agreement	78473-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	78473-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	78473-Language certificate.pdf
Peer-review Report	78473-Peer-review(s).pdf
Scientific Misconduct Check	78473-Bing-Wang DM-1.png
Scientific Misconduct Check	78473-CrossCheck.png
Scientific Editor Work List	78473-Scientific editor work list.pdf